Evidence-based recommendations for energy intake in pregnant women with obesity.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
01 08 2019
Historique:
entrez: 2 8 2019
pubmed: 2 8 2019
medline: 17 6 2020
Statut: epublish

Résumé

In women with obesity, excess gestational weight gain (≥270 g/week) occurs in two out of three pregnancies and contributes to metabolic impairments in both mother and baby. To improve obstetrical care, objectively assessed information on energy balance is urgently needed. The objective of this study was to characterize determinants of gestational weight gain in women with obesity. This was a prospective, observational study of pregnant women with obesity. The primary outcome was energy intake calculated by the energy intake-balance method. Energy expenditure was measured by doubly-labeled water and whole-room indirect calorimetry and body composition as 3-compartment model by air displacement plethysmography and isotope dilution in early (13-16 weeks) and late pregnancy (35-37 weeks). In pregnant women with obesity (n=54), recommended weight gain (n=8, 15%) during the second and third trimesters was achieved when energy intake was 125±52 kcal/d less than energy expenditure. In contrast, women with excess weight gain (67%) consumed 186±29 kcal/d more than they expended (P<0.001). Energy balance affected maternal adiposity (recommended: -2.5±0.8 kg fat mass, excess: +2.2±0.5, inadequate: -4.5±0.5, P<0.001), but not fetal growth. Weight gain was not related to demographics, activity, metabolic biomarkers, or diet quality. We estimated that energy intake requirements for recommended weight gain during the second and third trimesters were not increased as compared to energy requirements early in pregnancy (34±53 kcal/d, P=0.83). We here provide the first evidence-based recommendations for energy intake in pregnant women with obesity. Contrary to current recommendations, energy intake should not exceed energy expenditure. This study was funded by the National Institutes of Health (R01DK099175; Redman, U54GM104940 and P30DK072476; Core support). clinicaltrials.gov: NCT01954342.

Sections du résumé

BACKGROUND
In women with obesity, excess gestational weight gain (≥270 g/week) occurs in two out of three pregnancies and contributes to metabolic impairments in both mother and baby. To improve obstetrical care, objectively assessed information on energy balance is urgently needed. The objective of this study was to characterize determinants of gestational weight gain in women with obesity.
METHODS
This was a prospective, observational study of pregnant women with obesity. The primary outcome was energy intake calculated by the energy intake-balance method. Energy expenditure was measured by doubly-labeled water and whole-room indirect calorimetry and body composition as 3-compartment model by air displacement plethysmography and isotope dilution in early (13-16 weeks) and late pregnancy (35-37 weeks).
RESULTS
In pregnant women with obesity (n=54), recommended weight gain (n=8, 15%) during the second and third trimesters was achieved when energy intake was 125±52 kcal/d less than energy expenditure. In contrast, women with excess weight gain (67%) consumed 186±29 kcal/d more than they expended (P<0.001). Energy balance affected maternal adiposity (recommended: -2.5±0.8 kg fat mass, excess: +2.2±0.5, inadequate: -4.5±0.5, P<0.001), but not fetal growth. Weight gain was not related to demographics, activity, metabolic biomarkers, or diet quality. We estimated that energy intake requirements for recommended weight gain during the second and third trimesters were not increased as compared to energy requirements early in pregnancy (34±53 kcal/d, P=0.83).
CONCLUSIONS
We here provide the first evidence-based recommendations for energy intake in pregnant women with obesity. Contrary to current recommendations, energy intake should not exceed energy expenditure.
FUNDING
This study was funded by the National Institutes of Health (R01DK099175; Redman, U54GM104940 and P30DK072476; Core support).
TRIAL REGISTRATION
clinicaltrials.gov: NCT01954342.

Identifiants

pubmed: 31369400
pii: 130341
doi: 10.1172/JCI130341
pmc: PMC6819141
doi:
pii:

Banques de données

ClinicalTrials.gov
['NCT01954342']

Types de publication

Clinical Trial Journal Article Observational Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

4682-4690

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR003097
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK099175
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK064584
Pays : United States
Organisme : NIGMS NIH HHS
ID : U54 GM104940
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Am J Clin Nutr. 2004 Jun;79(6):1078-87
pubmed: 15159239
Obesity (Silver Spring). 2014 Sep;22(9):1989-96
pubmed: 25164259
Am J Clin Nutr. 2009 Nov;90(5):1303-13
pubmed: 19759171
Obstet Gynecol. 2011 Sep;118(3):569-75
pubmed: 21860285
J Clin Endocrinol Metab. 2017 Mar 1;102(3):903-913
pubmed: 27935767
Obesity (Silver Spring). 2018 Mar;26(3):485-491
pubmed: 29464907
Int J Obes (Lond). 2008 Mar;32(3):495-501
pubmed: 18227847
Obesity (Silver Spring). 2018 Jun;26(6):992-999
pubmed: 29797559
JAMA. 2016 Jun 7;315(21):2284-91
pubmed: 27272580
Lancet Diabetes Endocrinol. 2015 Oct;3(10):767-77
pubmed: 26165396
J Nutr. 2018 Apr 1;148(4):658-663
pubmed: 29659958
Obes Sci Pract. 2016 Mar 18;2(2):174-179
pubmed: 29071098
Am J Obstet Gynecol. 2019 Jan;220(1):119-120
pubmed: 30171842
BMJ. 2014 Feb 10;348:g1285
pubmed: 24513442
Epidemiology. 2016 Nov;27(6):894-902
pubmed: 27682365
Obesity (Silver Spring). 2012 Apr;20(4):891-9
pubmed: 22134199
Obesity (Silver Spring). 2018 Sep;26(9):1396-1404
pubmed: 30230252
Mol Metab. 2016 Sep 20;5(11):1057-1071
pubmed: 27818932
Ultrasound Obstet Gynecol. 2009 Nov;34(5):556-65
pubmed: 19725080
Cell Metab. 2019 Feb 5;29(2):231-233
pubmed: 30595480
Am J Clin Nutr. 1999 Apr;69(4):697-704
pubmed: 10197571
Obstet Gynecol. 2016 May;127(5):884-92
pubmed: 27054928
Eur J Clin Nutr. 2018 May;72(5):645-656
pubmed: 29748651
Diabetes Care. 2015 Sep;38(9):1650-6
pubmed: 26112044
Am J Clin Nutr. 1993 Apr;57(4):494-505
pubmed: 8460604
Am J Obstet Gynecol. 2014 Feb;210(2):134.e1-9
pubmed: 24060449
Obstet Gynecol. 2015 Apr;125(4):773-81
pubmed: 25751216
J Natl Med Assoc. 2009 Jun;101(6):569-77
pubmed: 19585925
J Matern Fetal Neonatal Med. 2014 Sep;27(13):1348-52
pubmed: 24175912
Public Health Nutr. 2011 Feb;14(2):290-6
pubmed: 20642871
Paediatr Perinat Epidemiol. 2012 Sep;26(5):479-94
pubmed: 22882792
Diabetes Care. 2016 Jan;39(1):24-30
pubmed: 26223239
Am J Clin Nutr. 2011 Apr;93(4):772-9
pubmed: 21310836
Am J Prev Med. 2018 Nov;55(5):603-614
pubmed: 30262148
Obstet Gynecol. 1997 Oct;90(4 Pt 1):483-8
pubmed: 9380301
Am J Clin Nutr. 2012 Jan;95(1):115-22
pubmed: 22170365
Obesity (Silver Spring). 2018 Mar;26(3):578-587
pubmed: 29464905
Am J Clin Nutr. 2018 Jun 1;107(6):957-964
pubmed: 29767680
Nutrients. 2019 Jun 26;11(7):null
pubmed: 31248020
Am J Clin Nutr. 2010 May;91(5):1336-41
pubmed: 20237138
Clin Physiol Funct Imaging. 2015 Jan;35(1):64-70
pubmed: 24393233

Auteurs

Jasper Most (J)

Reproductive Endocrinology and Women's Health, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.

Marshall St Amant (MS)

Maternal and Fetal Medicine, Woman's Hospital, Baton Rouge, Louisiana, USA.

Daniel S Hsia (DS)

Reproductive Endocrinology and Women's Health, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.

Abby D Altazan (AD)

Reproductive Endocrinology and Women's Health, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.

Diana M Thomas (DM)

United States Military Academy, West Point, New York, USA.

L Anne Gilmore (LA)

Reproductive Endocrinology and Women's Health, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.

Porsha M Vallo (PM)

Reproductive Endocrinology and Women's Health, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.

Robbie A Beyl (RA)

Reproductive Endocrinology and Women's Health, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.

Eric Ravussin (E)

Reproductive Endocrinology and Women's Health, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.

Leanne M Redman (LM)

Reproductive Endocrinology and Women's Health, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH